CONSULTING AGREEMENT FOR SCIENTIFIC ADVISORY BOARD MEMBERSConsulting Agreement • June 22nd, 2009 • SignPath Pharma, Inc. • Pharmaceutical preparations • New York
This Agreement entered into this 1st_ day of July, 2007, by and between Sign Path Pharma, Inc. (“Sign Path”), a Delaware corporation, with its principal place of business at [1375 California Road, Quakertown, PA, 18951] and Lawrence Helson MD, a Scientific Advisory Board member] f 1375 California Road Quakertown, Pennsylvania 18951, USA
Agreement for the Manufacturing of a Liposomal FormulationSignPath Pharma, Inc. • June 22nd, 2009 • Pharmaceutical preparations
Contractor is obliged to maintain the Contractual Intellectual Property Rights during the term of this Agreement at his own costs.
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • June 22nd, 2009 • SignPath Pharma, Inc. • Pharmaceutical preparations • Texas
This Sponsored Research Agreement (the "Agreement") is made between the University of North Texas Health Science Center at Fort Worth, ("University"), a component institution of the University of North Texas System ("System"), and SignPath Pharmaceuticals, Inc. a Delaware corporation with its principal place of business at 45 Broadway, 2nd Floor New York, NY 10006 ("Sponsor").
PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • June 22nd, 2009 • SignPath Pharma, Inc. • Pharmaceutical preparations • Texas
This thirty-four (34) page AGREEMENT ("AGREEMENT") is made on this 18th day of August, 2008, by and between THE UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER at FORT WORTH (UNTHSC), a State of Texas institution of higher education, whose address is 3500 Camp Bowie Blvd. Fort Worth, Texas 76107-2699, and SIGNPATH PHARMACEUTICALS, INC., a Delaware corporation having a principal place of business located at 45 Broadway, 2nd Floor New York, NY 10006 ("LICENSEE").
SERVICE AGREEMENTService Agreement • June 22nd, 2009 • SignPath Pharma, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (“Agreement”), effective January 30, 2008 (the "Effective Date"), is by and between Sign Path Pharmaceuticals, Inc., a company incorporated in the State of Delaware and having its office at Office at 45 Broadway 2nd Floor New York, NY 10006, USA (“CLIENT”) and BROOKWOOD PHARMACEUTICALS, INC having a principal place of business at 756 Tom Martin Drive, Birmingham, Alabama 35211 ("BROOKWOOD").
SPONSORED RESEARCH AGREEMENTSponsored Research Agreement • June 22nd, 2009 • SignPath Pharma, Inc. • Pharmaceutical preparations • Maryland
This agreement (the “Agreement”) is entered into as of this eighteenth day of September, 2007 (the “Effective Date”), by and between The Johns Hopkins University, having a School of Medicine located at 733 North Broadway, Suite 117 Baltimore, Maryland, 21205 (the “Institution”), employer of Dr. Anirban Maitra (the “Investigator”), and Sign Path Pharma, Inc., a corporation organized under the laws of the State of Delaware, located at 1375 California Road, Quakertown, PA 18951, USA (the “Sponsor”).
